12
Views
40
CrossRef citations to date
0
Altmetric
Article

A Modular Enhancer Is Differentially Regulated by GATA and NFAT Elements That Direct Different Tissue-Specific Patterns of Nucleosome Positioning and Inducible Chromatin Remodeling

, , &
Pages 2870-2885 | Received 12 Dec 2006, Accepted 27 Jan 2007, Published online: 27 Mar 2023

REFERENCES

  • Avots, A., M. Buttmann, S. Chuvpilo, C. Escher, U. Smola, A. J. Bannister, U. R. Rapp, T. Kouzarides, and E. Serfling. 1999. CBP/p300 integrates Raf/Rac-signaling pathways in the transcriptional induction of NF-ATc during T cell activation. Immunity 10:515–524.
  • Baxter, E. W., W. J. Cummings, and R. E. Fournier. 2005. Formation of a large, complex domain of histone hyperacetylation at human 14q32.1 requires the serpin locus control region. Nucleic Acids Res. 33:3313–3322.
  • Bert, A. G., J. Burrows, A. Hawwari, M. A. Vadas, and P. N. Cockerill. 2000. Reconstitution of T cell-specific transcription directed by composite NFAT/Oct elements. J. Immunol. 165:5646–5655.
  • Butterfield, J. H., and D. A. Weiler. 1989. In vitro sensitivity of immature human mast cells to chemotherapeutic agents. Int. Arch. Allergy Appl. Immunol. 89:297–300.
  • Carey, M. 1998. The enhanceosome and transcriptional synergy. Cell 92:5–8.
  • Cavalli, G., and F. Thoma. 1993. Chromatin transitions during activation and repression of galactose-regulated genes in yeast. EMBO J. 12:4603–4613.
  • Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363–2373.
  • Chen, L. 1999. Combinatorial gene regulation by eukaryotic transcription factors. Curr. Opin. Struct. Biol. 9:48–55.
  • Cockerill, P. N. 2004. Mechanisms of transcriptional regulation of the human IL-3/GM-CSF locus by inducible tissue-specific promoters and enhancers. Crit. Rev. Immunol. 24:385–408.
  • Cockerill, P. N., A. G. Bert, F. Jenkins, G. R. Ryan, M. F. Shannon, and M. A. Vadas. 1995. Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Mol. Cell. Biol. 15:2071–2079.
  • Cockerill, P. N., A. G. Bert, D. Roberts, and M. A. Vadas. 1999. The human GM-CSF gene is autonomously regulated in vivo by an inducible tissue-specific enhancer. Proc. Natl. Acad. Sci. USA 96:15097–15102.
  • Cohen, R. B., and M. Sheffery. 1985. Nucleosome disruption precedes transcription and is largely limited to the transcribed domain of globin genes in murine erythroleukemia cells. J. Mol. Biol. 182:109–129.
  • Dong, C., and R. A. Flavell. 2001. Th1 and Th2 cells. Curr. Opin. Hematol. 8:47–51.
  • Drew, E., H. Merkens, S. Chelliah, R. Doyonnas, and K. M. McNagny. 2002. CD34 is a specific marker of mature murine mast cells. Exp. Hematol. 30:1211.
  • Fan, H. Y., X. He, R. E. Kingston, and G. J. Narlikar. 2003. Distinct strategies to make nucleosomal DNA accessible. Mol. Cell 11:1311–1322.
  • Fan, Y., T. Nikitina, J. Zhao, T. J. Fleury, R. Bhattacharyya, E. E. Bouhassira, A. Stein, C. L. Woodcock, and A. I. Skoultchi. 2005. Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation. Cell 123:1199–1212.
  • Garcia-Rodriguez, C., and A. Rao. 1998. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J. Exp. Med. 187:2031–2036.
  • Hawwari, A., J. Burrows, M. A. Vadas, and P. N. Cockerill. 2002. The human IL-3 locus is regulated cooperatively by two NFAT-dependent enhancers that have distinct tissue-specific activities. J. Immunol. 169:1876–1886.
  • Holloway, A. F., S. Rao, X. Chen, and M. F. Shannon. 2003. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins. J. Exp. Med. 197:413–423.
  • Ito, T., M. Yamauchi, M. Nishina, N. Yamamichi, T. Mizutani, M. Ui, M. Murakami, and H. Iba. 2001. Identification of SWI.SNF complex subunit BAF60a as a determinant of the transactivation potential of Fos/Jun dimers. J. Biol. Chem. 276:2852–2857.
  • Johnson, B. V., A. G. Bert, G. R. Ryan, A. Condina, and P. N. Cockerill. 2004. Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. Mol. Cell. Biol. 24:7914–7930.
  • Kim, A., and A. Dean. 2003. A human globin enhancer causes both discrete and widespread alterations in chromatin structure. Mol. Cell. Biol. 23:8099–8109.
  • Kim, Y., N. McLaughlin, K. Lindstrom, T. Tsukiyama, and D. J. Clark. 2006. Activation of Saccharomyces cerevisiae HIS3 results in Gcn4p-dependent, SWI/SNF-dependent mobilization of nucleosomes over the entire gene. Mol. Cell. Biol. 26:8607–8622.
  • Kwan, M., D. R. Powell, T. Y. Nachman, and M. A. Brown. 2005. An intron GATA-binding site regulates chromatin accessibility and is essential for IL-4 gene expression in mast cells. Eur. J. Immunol. 35:1267–1274.
  • Lefevre, P., C. Lacroix, H. Tagoh, M. Hoogenkamp, S. Melnik, R. Ingram, and C. Bonifer. 2005. Differentiation-dependent alterations in histone methylation and chromatin architecture at the inducible chicken lysozyme gene. J. Biol. Chem. 280:27552–27560.
  • Lodha, M., and M. Schroda. 2005. Analysis of chromatin structure in the control regions of the chlamydomonas HSP70A and RBCS2 genes. Plant Mol. Biol. 59:501–513.
  • Masuda, A., Y. Yoshikai, H. Kume, and T. Matsuguchi. 2004. The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J. Immunol. 173:5564–5573.
  • Merika, M., and D. Thanos. 2001. Enhanceosomes. Curr. Opin. Genet. Dev. 11:205–208.
  • Merika, M., A. J. Williams, G. Chen, T. Collins, and D. Thanos. 1998. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol. Cell 1:277–287.
  • Monticelli, S., D. U. Lee, J. Nardone, D. L. Bolton, and A. Rao. 2005. Chromatin-based regulation of cytokine transcription in Th2 cells and mast cells. Int. Immunol. 17:1513–1524.
  • Orkin, S. H. 1995. Hematopoiesis: how does it happen? Curr. Opin. Cell Biol. 7:870–877.
  • Rodriguez, P., E. Bonte, J. Krijgsveld, K. E. Kolodziej, B. Guyot, A. J. Heck, P. Vyas, E. de Boer, F. Grosveld, and J. Strouboulis. 2005. GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J. 24:2354–2366.
  • Shogren-Knaak, M., H. Ishii, J. M. Sun, M. J. Pazin, J. R. Davie, and C. L. Peterson. 2006. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311:844–847.
  • Tsai, E. Y., J. V. Falvo, A. V. Tsytsykova, A. K. Barczak, A. M. Reimold, L. H. Glimcher, M. J. Fenton, D. C. Gordon, I. F. Dunn, and A. E. Goldfeld. 2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol. Cell. Biol. 20:6084–6094.
  • Walsh, J. C., R. P. DeKoter, H. J. Lee, E. D. Smith, D. W. Lancki, M. F. Gurish, D. S. Friend, R. L. Stevens, J. Anastasi, and H. Singh. 2002. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 17:665–676.
  • Xu, M., M. B. Barnard, S. M. Rose, P. N. Cockerill, S. Y. Huang, and W. T. Garrard. 1986. Transcription termination and chromatin structure of the active immunoglobulin kappa gene locus. J. Biol. Chem. 261:3838–3845.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.